40 related articles for article (PubMed ID: 24732358)
1. Telomere length and risk of cirrhosis, hepatocellular carcinoma, and cholangiocarcinoma in 63,272 individuals from the general population.
Gellert-Kristensen H; Bojesen SE; Tybjærg Hansen A; Stender S
Hepatology; 2024 Apr; 79(4):857-868. PubMed ID: 37732945
[TBL] [Abstract][Full Text] [Related]
2. Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.
Farmery JHR; Smith ML; ; Lynch AG
Sci Rep; 2018 Jan; 8(1):1300. PubMed ID: 29358629
[TBL] [Abstract][Full Text] [Related]
3. Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma.
Mender I; Siteni S; Barron S; Flusche AM; Kubota N; Yu C; Cornelius C; Tedone E; Maziveyi M; Grichuk A; Venkateswaran N; Conacci-Sorrell M; Hoshida Y; Kang R; Tang D; Gryaznov S; Shay JW
Mol Cancer Ther; 2023 Jun; 22(6):737-750. PubMed ID: 37070671
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional outcome of telomere signalling.
Ye J; Renault VM; Jamet K; Gilson E
Nat Rev Genet; 2014 Jul; 15(7):491-503. PubMed ID: 24913665
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study.
Casadei-Gardini A; Scarpi E; Ulivi P; Palladino MA; Accettura C; Bernardini I; Spallanzani A; Gelsomino F; Corbelli J; Marisi G; Ruscelli S; Valgiusti M; Frassineti GL; Passardi A
Cancer Manag Res; 2019; 11():4357-4369. PubMed ID: 31191000
[No Abstract] [Full Text] [Related]
6. Heterogeneous Nuclear Ribonucleoproteins Involved in the Functioning of Telomeres in Malignant Cells.
Shishkin SS; Kovalev LI; Pashintseva NV; Kovaleva MA; Lisitskaya K
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744200
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial.
Casadei Gardini A; Scarpi E; Orlandi E; Tassinari D; Leo S; Bernardini I; Gelsomino F; Tamberi S; Ruscelli S; Vespignani R; Ronconi S; Frassineti GL; Amadori D; Passardi A
Onco Targets Ther; 2018; 11():5261-5268. PubMed ID: 30214231
[TBL] [Abstract][Full Text] [Related]
8. Association of
Zhang Y; Wang S; Wen X; Zhang S; Yang Y
Oncotarget; 2017 Oct; 8(49):86011-86019. PubMed ID: 29156773
[TBL] [Abstract][Full Text] [Related]
9. Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.
Yang B; Shebl FM; Sternberg LR; Warner AC; Kleiner DE; Edelman DC; Gomez A; Dagnall CL; Hicks BD; Altekruse SF; Hernandez BY; Lynch CF; Meltzer PS; McGlynn KA
PLoS One; 2016; 11(11):e0166828. PubMed ID: 27880792
[TBL] [Abstract][Full Text] [Related]
10. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
[TBL] [Abstract][Full Text] [Related]
11. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
Ko E; Seo HW; Jung ES; Kim BH; Jung G
Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
[TBL] [Abstract][Full Text] [Related]
12. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
Jin J; Zhu P; Liao Y; Li J; Liao W; He S
Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent cytotoxic effects of boldine in HepG-2 cells-telomerase inhibition and apoptosis induction.
Noureini SK; Wink M
Molecules; 2015 Feb; 20(3):3730-43. PubMed ID: 25719742
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of the isoquinoline alkaloid papaverine in hepatocarcinoma HepG-2 cells--inhibition of telomerase and induction of senescence.
Noureini SK; Wink M
Molecules; 2014 Aug; 19(8):11846-59. PubMed ID: 25111025
[TBL] [Abstract][Full Text] [Related]
15. Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells.
Ko E; Jung G
Biochem Biophys Res Commun; 2014 May; 447(2):358-63. PubMed ID: 24732358
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.
Chen J; Zhang B; Wong N; Lo AW; To KF; Chan AW; Ng MH; Ho CY; Cheng SH; Lai PB; Yu J; Ng HK; Ling MT; Huang AL; Cai XF; Ko BC
Cancer Res; 2011 Jun; 71(12):4138-49. PubMed ID: 21527554
[TBL] [Abstract][Full Text] [Related]
17. Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.
Ko E; Seo HW; Jung G
Hepatology; 2018 Apr; 67(4):1378-1391. PubMed ID: 29059467
[TBL] [Abstract][Full Text] [Related]
18. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
19. [Telomere length and telomerase activity in hepatocellular carcinoma].
Nakashio R; Kitamoto M; Nakanishi T; Takaishi H; Takahashi S; Kajiyama G
Nihon Rinsho; 1998 May; 56(5):1239-43. PubMed ID: 9613130
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
